Ashish_Munjal_WongWH1.14Dr Ashish Munjal (left) is the Chief Operating Officer of Cryoviva Singapore, a JV between AsiaMedic (CEO is Dr Wong Weng Hong, right) and Cryoviva International. Photo by Sim Kih

What's happening?

THE NEW YEAR has ushered in a new service provider for cord-blood banking in Singapore  -- the fourth after listed company Cordlife, private company StemCord and public provider Singapore Cord Blood Bank.  

Cryoviva Singapore, the newest entrant in this burgeoning business, has recently received the necessary licence for its facility, Cryoviva (Singapore) Laboratory Services, from the Ministry of Health in Singapore.

Cryoviva is a 75-25 joint venture between Cryoviva International and AsiaMedic Limited.

Cryoviva International's promoters have established similar businesses in India and Thailand which have emerged as the No.2 and a leading player, respectively, within just a couple of years.

Ravi-Jaipuria_ekantipur.comRavi Jaipuria, chairman of RJ Corp, the largest PepsiCo bottler in India. Photo: www.ekantipur.comWho the partners are

Cryoviva International is 70%-owned by Mr Ravi Jaipuria, Chairman of India-based RJ Corp, a conglomerate with businesses in real estate, hospitality, food & beverage, healthcare and education.

The remaining 30% is held by Dr T Chandroo, Chairman of Modern Montessori International Group, a Singapore company which specialises in early childhood education in the Asia-Pacific region.

Singapore-based and listed AsiaMedic is a new player in cord-blood banking but it offers local business insights to its partner -- in addition to housing the operations of Cryoviva Singapore on its premises in Shaw House in Orchard Road.

AsiaMedic's participation in the JV is one of the key moves the company has made since Dr Wong Weng Hong came on board as its CEO in March 2012.

Back then, it had two core businesses -- radiology and health screening -- and these were Singapore-centric. Now, AsiaMedic also owns majority stakes in Complete Healthcare International (a GP practice targeted at expats) and Astique The Aesthetic Clinic (an aesthetic business).

It also has created a mini-medical hub in Shaw House by leasing the entire 8th and 10th floors and sub-leasing space to several sub-tenants, some of whom require the advanced imaging services of AsiaMedic. AsiaMedic is also in the early stages of building a business for its services in China, Myanmar and Indonesia.

(See: ASIAMEDIC: From just 2 revenue streams to many, including cord-blood bank business)

What's the Singapore market's potential?

Singapore reported 42,663 births in 2012, up 7.4% from a year earlier.

The compound annual growth rate for private cord blood banking is projected to grow faster, at 9%, from 2011 to 2015, according to Deloitte & Touche Financial Advisory Services.

As it is, Singapore has a relatively high penetration rate of private cord blood banking at approximately 19% in 2011.

Deloitte expects this figure to rise to 25% by 2015, mainly driven by effective marketing activities by the service providers and increasing public awareness and acceptance levels.

Cryoviva Singapore is also eyeing business beyond Singapore's shores.

Dr Ashish Munjal, its Chief Operating Officer, said: “Singapore is an excellent place as a springboard for Cryoviva Singapore to expand into the region. We will be coming up with new initiatives to grow the business and forge ahead with expansion plans in the neighbouring ASEAN countries where urban populations are becoming increasingly better educated and wealthier."

What's cord blood banking?

It is the collection at birth, processing, testing, cryopreservation and storage of stem cells from the umbilical cord blood.

Blood stem cell transplants offer a potential hope of cure for a number of life-threatening cancers, auto immune disorders and blood diseases. Cord blood is currently being used to treat malignant diseases such as leukaemia, lymphoma and numerous other types of cancer. 

It is also being used to treat non-malignant diseases such as severe aplastic anaemia (when the blood is dangerously deficient in healthy red blood cells), thalassemia (a blood condition that interferes with haemoglobin production), and systemic sclerosis (a chronic auto immune disorder that can affect vital internal organs).  

While these are known diseases that cord blood is being used to treat, stem cell transplants have been identified as a promising area for further clinical development. Medical professionals worldwide are optimistic of the future treatment possibilities as ongoing research has shown stem cells’ growing potential to treat a host of other diseases.  

Source: Singapore Cord Blood Bank ( 

drashish_vertDr Ashish Munjal has several years of experience in the cord blood banking business, having served as General Manager of RJ Corp's healthcare division (Cryobanks International India). Photo by Leong Chan TeikWhat differentiates Cryoviva Singapore?

While Cordlife and StemCord carry out their processing and storage activities (and own facilities in Singapore), Cryoviva Singapore prefers to contract Singapore Cord Blood Bank (SCBB) to do so.

Located in KK Women & Children's Hospital in Bt Timah Road, SCBB describes itself as a "national resource that is supported by Singapore's public healthcare clusters." 

Explaining Cryoviva Singapore's choice, Dr Munjal described the protocols practised by SCBB as being "very stringent," adding that "the quality standards we wanted to offer to the market are fulfilled by SCBB."

With a new service provider, cordblood banking looks set to become better understood by parents-to-be in Singapore. 

See AsiaMedic's press release on the appointment of Singapore Cord Blood Bank here. 

You may also be interested in:


+3 #1 cord donor 2014-02-21 13:49
Cord banking is a long term business. 20 yrs, if you don't have their own facitilites and if one day SCBB decides not to do contracting for them then how?

You have no rights to post comments

Counter NameLastChange
AEM Holdings2.430-0.050
Best World2.4900.020
Boustead Singapore0.945-0.010
Broadway Ind0.134-0.005
China Aviation Oil (S)0.925-0.025
China Sunsine0.405-0.005
Delfi Limited0.915-0.010
Food Empire1.330-0.030
Fortress Minerals0.320-
Geo Energy Res0.315-0.010
Hong Leong Finance2.490-
Hongkong Land (USD)2.950-0.040
ISDN Holdings0.300-0.010
IX Biopharma0.046-0.006
KSH Holdings0.250-
Leader Env0.049-
Ley Choon0.044-
Marco Polo Marine0.068-0.001
Mermaid Maritime0.145-0.002
Nordic Group0.315-0.050
Oxley Holdings0.089-0.001
REX International0.145-0.001
Southern Alliance Mining0.485-
Straco Corp.0.495-
Sunpower Group0.215-0.005
The Trendlines0.0740.004
Totm Technologies0.024-0.001
Uni-Asia Group0.8300.010
Wilmar Intl3.490-0.050
Yangzijiang Shipbldg1.7800.010

We have 1011 guests and no members online

rss_2 NextInsight - Latest News